SlideShare a Scribd company logo
1 of 111
MEDICATION ABUSE: Over-the-Counter & Prescription  Drug Abuse & Dependence Rand L. Kannenberg, M.A., LAC, CCM, CCS
Table of Contents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dedication ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Statistics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
About the Presenter ,[object Object],[object Object]
Program Description ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],At the end of this seminar the participant will be able to:
Agenda & Outline ,[object Object],[object Object],[object Object],[object Object]
Schedule II. (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence. Schedule III. (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. Schedule IV. (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III. Schedule V. (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV. U.S. Drug Enforcement Administration (DEA) Schedules of controlled substances
Opioids  & morphine derivatives      hydrocodone (Schedules II, III, V)   Examples  Hydrocodone with Acetaminophen, Vicodin®, Vicoprofen®, Tussionex®, Lortab®, Tussend®, Hycodan®, Anexsia® Nicknames vike, Watson-387  Route of Administration swallowed Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest,  unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Opioids  & morphine derivatives      oxycodone (Schedule II)   Examples Roxicet®, Oxycodone with Acetaminophen, OxyContin®, Endocet®, Percocet®, Percodan®, Tylox®, Roxicodone® Nicknames Oxy, O.C., killer  Route of Administration swallowed, snorted, injected  Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Opioids  & morphine derivatives      ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids  & morphine derivatives      morphine (Schedules II, III) Examples Duramorph®, MS-Contin®, Roxanol®, Oramorph SR®, RMS®  Nicknames M, Miss Emma, monkey, white stuff  Route of Administration injected, swallowed, smoked  Desired Outcomes pain relief, euphoria  Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils,  slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Opioids  & morphine derivatives      hydro-morphone (Schedule II)   Examples Dilaudid ®,  dihydromorphinone  Nicknames Dust, Juice, Smack, D, Footballs  Route of Administration swallowed, injected Desired Outcomes pain relief, euphoria  Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils,  slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Opioids  & morphine derivatives      opium (Schedules II, III, V) Examples laudanum, paregoric, papaver somniferum, extracts/fluid/poppy/tincture/granulated/powdered/raw, Parepectolin®, Kapectolin PG®, Kaolin®, Pectin P.G.® Nicknames big O, black stuff, block, gum, hop  Route of Administration swallowed, smoked  Desired Outcomes pain relief, euphoria  Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils,  slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Opioids  & morphine derivatives      other narcotics (Schedules II, III, IV) Examples Actiq®, Duragesic®, Sublimaze®, Fentanyl®, Demerol®, methadone, Darvon®, Darvocet®, Stadol®, Talwin®, Paregoric®, Buprenex®, propoxyphene, Propacet®, Innovar®, Mepergan®, pethidine Nicknames Apache, China girl, China white, dance fever, friend, goodfella, jackpot, murder 8, TNT, Tango and Cash  Route of Administration swallowed, injected, smoked, snorted  Desired Outcomes pain relief, euphoria  Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils,  slow and shallow breathing, clammy skin, convulsions, possible death  National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Video #1 “Opioids” (3 minutes & 8 seconds) “ Prescription Drugs: Killing More Than Pain”
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CNS depressants    barbiturates (Schedules II, III, IV) Examples (methohexital) Brevital®, (thiamyl) Surital®, (thiopental) Pentothal®, (amobarbital) Amyta®, (pentobarbital) Nembutal®, (secobarbital) Seconal®, (amobarbital/secobarbital) Tuinal®, (butalbital) Fiorina®, (butabarbital) Butisol®, (talbutal) Lotusate®, (aprobarbital) Alurate®, (phenobarbital) Luminal®, (mephobarbital) Mebaral® Nicknames barbs, reds, red birds, phennies, tooies, yellows, yellow jackets  Route of Administration injected, swallowed  Desired Outcomes reduced pain and anxiety; feeling of well-being; lowered inhibitions  Adverse Reactions slowed pulse and breathing, lowered blood pressure, poor concentration/fatigue, confusion, impaired coordination/memory/judgment,  respiratory depression and arrest, death, sedation, drowsiness/depression, unusual excitement, fever, irritability, poor judgment, slurred speech, dizziness, life-threatening withdrawal   National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
CNS depressants  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CNS depressants  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Video #2 “Benzos”   (2 minutes & 46 seconds) “ Prescription Drugs: Killing More Than Pain”
Dissociative anesthetics  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Stimulants ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Stimulants cocaine (Schedule II) Examples Cocaine hydrochloride  Nicknames blow, bump, C, candy, Charlie, coke, crack, flake, rock, snow, toot  Route of Administration swallowed, snorted, injected, smoked Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions dysphoric crash, death from respiratory failure, strokes, heart failure, increased heart rate, high blood pressure, increased metabolism, irregular heart beat, weight loss, nervousness, insomnia, increased temperature, chest pain, nausea, abdominal pain, seizures, headaches, malnutrition, panic attacks Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Stimulants methamphetamine (Schedule II) Example Desoxyn® Nicknames chalk, crank, crystal, fire, glass, go fast, ice, meth, speed  Route of Administration swallowed, snorted, injected, smoked Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions inability to sleep, loss of appetite and weight, thin/gaunt, increased sensitivity to noise, agitation, restlessness, irritability, aggressiveness, dizziness, confusion, impaired judgment, diarrhea and gastrointestinal complaints, difficulty breathing, headaches, tremors or seizures, nausea and vomiting, numbness, profuse sweating, chills, muscle cramping, pain and tenderness, dehydration, low magnesium level, low potassium level, grossly dilated pupils, chest pain, increased or decreased heart rate, increased blood pressure, fever or hyperthermia, impaired speech and language, mania, psychosis with hallucinations and delusions, anxiety, panic, fear of impending doom, depression and suicidal ideation, poor hygiene and body malodor, missing teeth, bleeding gums, infected gums, dental caries/decay/cavities, dry mouth, removed enamel, teeth grinding, skin aging and damage, dryness, roughness, wrinkles, broken veins, dermatitis around the mouth, skin ulceration and infection, acne or sores, hair loss from repetitious pulling Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Stimulants methylphenidate (Schedule II) Examples Ritalin®, Methylin®, Concerta® Nicknames JIF, MPH, R-ball, Skippy, the smart drug, vitamin R  Route of Administration swallowed, snorted, injected Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions increased heart rate, high blood pressure, increased metabolism, irregular heart beat, weight loss, heart failure, nervousness, insomnia Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
Anabolic steroids (Schedule III) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dextromethorphan  (DXM) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Video #3 “DXM”   (1minute & 50 seconds) ,[object Object]
Weight loss pills Examples bitter orange, chitosan, chromium, conjugated linoleic acid (CLA), county mallow (heartleaf), ephedra, green tea extract, guar gum, hoodia Nicknames same as above Route of Administration swallowed Desired Outcomes decrease appetite, block absorption of dietary fat, reduce fat, build muscle, increase calorie and fat metabolism, increase the feeling of fullness Adverse Reactions constipation, bloating, diarrhea, indigestion, high blood pressure, heart rate irregularities, sleeplessness, seizures, heart attacks, strokes, death, vomiting, flatulence Mayo Clinic
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sleeping aids ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Online or e-pharmacies  fax broadcasting/blasting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.suremedlink.com
Minors ordering on the Internet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Street use ,[object Object],[object Object],[object Object]
“Pill mills” ,[object Object],[object Object],[object Object],[object Object]
Identifying  Drug-Seeking  Patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case Study 1 ,[object Object],[object Object],[object Object]
Case Study 2 ,[object Object],[object Object],[object Object],[object Object],[object Object]
“Opiophobia”  ,[object Object],[object Object]
Characteristics of overprescribing physicians ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How to approach physicians with concerns ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Types of fraudulent prescriptions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Characteristics of forged prescriptions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Other warning signs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Prescription fraud prevention techniques ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reasons for drug testing ,[object Object],[object Object],[object Object],[object Object],[object Object]
Types of drug testing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Detection periods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Alternatives to controlled drugs for anxiety ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Alternatives to controlled drugs for insomnia ,[object Object],[object Object]
Alternatives to controlled drugs for ADHD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Alternatives to controlled drugs for pain ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Suboxone ®  versus Methadone or LAAM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Warning signs of impaired professionals ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Guidelines for Writing Prescriptions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Do these 3 things when writing prescriptions ,[object Object],[object Object],[object Object],American Family Physician
“Clinical Sobriety Checklist” (CSC)™  for medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
_____legal, illegal, prescription and over-the-counter substance(s) used;  _____amount/route of administration/frequency/duration of use;  _____when started using; _____why using/used;  _____last use; _____blood alcohol level and time;  _____breath test result and time;  _____urine drug screen results and time;  _____CIWA score and time;  _____COWS score and time;  _____CAGE score; Kannenberg Prescription drug interview questions
  _____history of blackouts;  _____history of intoxication or withdrawal delirium;  _____history of intoxication or withdrawal seizures;  _____history of substance induced psychosis, mania, anxiety or depression;  _____longest time clean/sober,  _____history of addiction treatment;  _____history of addiction support;  _____history of addiction education;  _____history of substance related legal problems;  _____history of physical problems as a result of using; and _____problems at home, work or school as a result of using.  Kannenberg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug addiction test ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Yes  No
21. Neglect food : I do not eat healthy foods or eat at regular times, especially when I'm using.  22. Resentment : I feel like other people are out to get me, and I feel angry a lot.  23. Withdrawal : I need a drink or a drug in the morning or else I get the shakes or sweats because I feel terrible.  24. Can't make decisions : I can't make decisions about even small things. I just wait until things happen.  19. Work and money troubles : I have problems on the job, owe money or can't work at all because of my using.  20. Avoid friends and family : I avoid old friends and family that do not use—unless I need something from them.  18. Make changes : I change jobs, move, or leave a relationship to try to make my life better, but it doesn't make any difference.  17. Give up other things : I've stopped doing things that I used to do that didn't involve using alcohol or drugs.  16. Control : I try to control my use, but it doesn't work.  15. Promises : I promise to get my life in order and do better. I mean it, but it doesn't work out that way.  14. Show off : I show off or get pushy with other people to feel better and prove that I am okay.  13. Feel bad : I feel bad about how my using hurts other people, but I don't know what to do about it.
37. Confinement : I have been in jails and mental wards because of my using.  36. Desperation : I am willing to do anything to get better.  35. I'm lost : I don't try to pretend my life is normal. I know I am an addict or an alcoholic. I believe that things will never change.  34. Turn to God : I want God or religion to save me from my life.  33. Using is everything : Getting something to use, using, and getting over using are my whole life.  32. Give up : I don't try to change anything. I just wait to see what happens.  31. Afraid : I feel like something terrible might happen to me, people are out to get me, and I have to be on guard at all times.  30. Major damage : Even when I'm not using, I have a hard time thinking, remembering, and doing things that used to be easy.  29. Find someone worse : I try to use with people who are worse off than I am so that I feel better.  28. Use all the time : I use whenever I can, and I don't try to have a normal life.  27. Over the line : I do things I said I would never do or things that do not reflect the way I was raised.  26. Decrease in amount to get high : It takes less for me to get high or doesn't matter how much I use because I can't get the effect I want.  25. Health problems : I am sick, have lost a lot of weight, or feel physically bad most of the time.
Scoring Sheet for Alcohol and Drug Addiction Test Early Stage Addiction Count up the number of  yes  answers you checked in questions 1–12 and write the number below.  Number of checks for questions 1–12 _____  If you have one or more checks in this section, there is a possibility that you are addicted to alcohol or drugs. This means that you use alcohol or drugs to try to solve problems and to make yourself feel better. While using alcohol or drugs will not really make things better, it will feel like it does. If you have any checks in this section, you have a possibility of becoming addicted if you keep using. The closer your score is to 12, the higher your chance of addiction.  Middle Stage Addiction   Count up the number of  yes  answers you checked in questions 13–24 and write the number below.  Number of checks for questions 13–24 ____  Any number of checks in this section means that you are addicted and have started to have bad things happen to you because of your addiction. During this stage, you may try to do things to control your addiction. Some of these may work for a while, but not for long. For questions 13–24, the closer your score is to 12, the more addicted you are, and the worse things will get if you do not get help.  Late Stage Addiction   Count up the number of  yes  answers you checked in questions 25–37 and write the number below.  Number of checks for questions 25–37 ____  Any number of checks in this section means that you are in the late stage of addiction. During this stage, you may have given up and thought that you could not do anything to change. Serious life problems, such as being sick, or going to jail or a mental ward, have happened or will happen to you if you do not try to get help. For questions 25–37, the closer your score is to 13, the more addicted you are. Your chances of dying are high if you continue to use.
Substance dependence screening ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Substance abuse screening ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Opioid Intoxication ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sedative, Hypnotic, or Anxiolytic Intoxication ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Stimulant Intoxication   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepine withdrawal symptom questionnaire ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Each moderate score is given a rating of 1 and each severe score a rating of 2. The maximum score possible is 40, unless of course additional symptoms are included.  Note also whether the symptoms occurred when the tablets were reduced or stopped, or if the symptoms occurred when the tablets were the same.  If the individual attains an overall score above 20 seek specialist medical help.  If the individual endorses a number of severe symptoms seek specialist medical help.  If the individual reports a number of new symptoms seek specialist medical help. Tyrer, Murphy and Riley
  For each item, write in the number that best describes the patient’s signs or symptom.  Rate on just the apparent relationship to opiate withdrawal.  For example, if heart rate is increased because the patient was jogging just prior to assessment, the increase pulse rate would not add to the score.   WESSON, Donald R., CNS Medications Development, Oakland, California;  Medications Development Committee, American Society of Addiction Medicine.  LING, Walter, Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences,  David Geffen School of Medicine at University of California, Los Angeles. Clinical   Opiate   Withdrawal   Scale  (COWS)   Patient’s Name:___________________________                          Date: ______________
Resting Pulse Rate :  (record beats per minute)                     Measured after patient is sitting or lying for one minute. 0 pulse rate 80 or below 1 pulse rate 81-100 2 pulse rate 101-120 4 pulse rate greater than 120 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.aic.cuhk.edu.hk/web8/Horners_sweating.jpg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.opt.indiana.edu/ecco/graphics/dilate.jpg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://images.jupiterimages.com/common/detail/39/98/23119839.jpg
http://www.kellogg.umich.edu/theeyeshaveit/symptoms/images/tearing.jpg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.brainexplorer.org/brain-images/tremor.jpg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://www.abc.net.au/science/news/img/health/yawning071204.jpg
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
http://content.answers.com/main/content/wp/en/2/23/Goose_bumps.jpg
      Score:  5-12 = mild;  13-24 = moderate;  25-36 = moderately severe; more than 36 = severe withdrawal                                   Total scores   with observer’s initials
Stimulant withdrawal  checklist  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adult Inpatient Medical Detoxification   Admission Criteria Checklist ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adult Inpatient Medical Detoxification   Admission Criteria Checklist ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adult Inpatient Medical Detoxification   Admission Criteria Checklist ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Social detoxification exclusion criteria ,[object Object],[object Object],[object Object],[object Object],[object Object]
OFFICE-BASED OUTPATIENT WITHDRAWAL TECHNIQUES USING (CLONIDINE) CATAPRES® FOR OPIATES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OFFICE-BASED OUTPATIENT WITHDRAWAL TECHNIQUES USING (DIAZEPAM) VALIUM® OR (CLONAZEPAM) KLONOPIN® FOR ANXIOLYTICS/SEDATIVES/HYPNOTICS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OFFICE-BASED OUTPATIENT WITHDRAWAL TECHNIQUES FOR COCAINE AND AMPHETAMINES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rapid detoxification ,[object Object],[object Object],[object Object]
The “4 Ds” of quitting medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Gorski and Kelley
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Gorski and Kelley
 
 
“ National Medicine Abuse Awareness Month ” set by the United States Senate for every   August  starting in 2007.
References and Resources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Drugs & Society Chapter 2
Drugs & Society Chapter 2Drugs & Society Chapter 2
Drugs & Society Chapter 2Michelle Meyer
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingMark Scott
 
Drugs & Society Chapter 1
Drugs & Society Chapter 1Drugs & Society Chapter 1
Drugs & Society Chapter 1Michelle Meyer
 
Chapter 1 Drugs and Society
Chapter 1 Drugs and SocietyChapter 1 Drugs and Society
Chapter 1 Drugs and SocietyMichelle Meyer
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPeltOPUNITE
 
Chapter 1 Drugs and Society
Chapter 1 Drugs and SocietyChapter 1 Drugs and Society
Chapter 1 Drugs and SocietyMichelle Meyer
 
Prescription Drug Misuse: Among Young Adults
Prescription Drug Misuse: Among Young AdultsPrescription Drug Misuse: Among Young Adults
Prescription Drug Misuse: Among Young Adultsamankhosa
 
Abuse And Misuse Of Medication
Abuse And Misuse Of MedicationAbuse And Misuse Of Medication
Abuse And Misuse Of MedicationZaineb Razzaq
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Bryan
 
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...OPUNITE
 
Drugs of abuse - Uncommon drugs - Pharmacology
Drugs of abuse - Uncommon drugs - PharmacologyDrugs of abuse - Uncommon drugs - Pharmacology
Drugs of abuse - Uncommon drugs - PharmacologyDr Venkatesh Karthikeyan
 
Drug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human RightsDrug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human RightsAvi Choudhary
 
Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004Patty Melody
 
Controversial Responses to Opioid Addiction
Controversial Responses to Opioid AddictionControversial Responses to Opioid Addiction
Controversial Responses to Opioid AddictionHerbert Klein
 
Dangerous Drugs
Dangerous DrugsDangerous Drugs
Dangerous DrugsLeo Garcia
 
drug addiction, criminal justice & human rights
drug addiction, criminal justice & human rightsdrug addiction, criminal justice & human rights
drug addiction, criminal justice & human rightsChaitanya Limbachiya
 
Drug dependance and abuse
Drug dependance and abuseDrug dependance and abuse
Drug dependance and abuseAbhi Keralli
 
Understanding susbstance use disorder
Understanding susbstance use disorderUnderstanding susbstance use disorder
Understanding susbstance use disorderHatch Compliance
 

What's hot (20)

Drugs & Society Chapter 2
Drugs & Society Chapter 2Drugs & Society Chapter 2
Drugs & Society Chapter 2
 
Prescription Drug Abuse in America
Prescription Drug Abuse in AmericaPrescription Drug Abuse in America
Prescription Drug Abuse in America
 
Methadone Clinical Guidelines
Methadone Clinical GuidelinesMethadone Clinical Guidelines
Methadone Clinical Guidelines
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 
Drugs & Society Chapter 1
Drugs & Society Chapter 1Drugs & Society Chapter 1
Drugs & Society Chapter 1
 
Chapter 1 Drugs and Society
Chapter 1 Drugs and SocietyChapter 1 Drugs and Society
Chapter 1 Drugs and Society
 
Peter VanPelt
Peter VanPeltPeter VanPelt
Peter VanPelt
 
Chapter 1 Drugs and Society
Chapter 1 Drugs and SocietyChapter 1 Drugs and Society
Chapter 1 Drugs and Society
 
Prescription Drug Misuse: Among Young Adults
Prescription Drug Misuse: Among Young AdultsPrescription Drug Misuse: Among Young Adults
Prescription Drug Misuse: Among Young Adults
 
Abuse And Misuse Of Medication
Abuse And Misuse Of MedicationAbuse And Misuse Of Medication
Abuse And Misuse Of Medication
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03
 
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
Web only rx16 presummit pillmills-mon_200_investigating and prosecuting pill ...
 
Drugs of abuse - Uncommon drugs - Pharmacology
Drugs of abuse - Uncommon drugs - PharmacologyDrugs of abuse - Uncommon drugs - Pharmacology
Drugs of abuse - Uncommon drugs - Pharmacology
 
Drug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human RightsDrug addiction, Criminal justice & Human Rights
Drug addiction, Criminal justice & Human Rights
 
Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004
 
Controversial Responses to Opioid Addiction
Controversial Responses to Opioid AddictionControversial Responses to Opioid Addiction
Controversial Responses to Opioid Addiction
 
Dangerous Drugs
Dangerous DrugsDangerous Drugs
Dangerous Drugs
 
drug addiction, criminal justice & human rights
drug addiction, criminal justice & human rightsdrug addiction, criminal justice & human rights
drug addiction, criminal justice & human rights
 
Drug dependance and abuse
Drug dependance and abuseDrug dependance and abuse
Drug dependance and abuse
 
Understanding susbstance use disorder
Understanding susbstance use disorderUnderstanding susbstance use disorder
Understanding susbstance use disorder
 

Similar to Medication Abuse Handouts by Rand L. Kannenberg

EVERFI Webinar: Evidence Based Prescription Drugs Program
EVERFI Webinar: Evidence Based Prescription Drugs ProgramEVERFI Webinar: Evidence Based Prescription Drugs Program
EVERFI Webinar: Evidence Based Prescription Drugs ProgramMichele Collu
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisOPUNITE
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverOPUNITE
 
Sub m mw actual
Sub m mw actualSub m mw actual
Sub m mw actualmwalsh2015
 
Cannabis talk 6 4-19 glenview
Cannabis talk 6 4-19 glenviewCannabis talk 6 4-19 glenview
Cannabis talk 6 4-19 glenviewAshwani Garg, MD
 
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...KemalAbdela2
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
National epidemiologic survey on alcohol and related conditions.seminar coorect
National epidemiologic survey on alcohol and related conditions.seminar coorectNational epidemiologic survey on alcohol and related conditions.seminar coorect
National epidemiologic survey on alcohol and related conditions.seminar coorectDr. Amit Chougule
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaOPUNITE
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaOPUNITE
 
8b3110 5e86f9f991724f258390ca750d1c321a
8b3110 5e86f9f991724f258390ca750d1c321a8b3110 5e86f9f991724f258390ca750d1c321a
8b3110 5e86f9f991724f258390ca750d1c321aMark Gold
 
Action research on drug safety assestment
Action research on drug safety assestmentAction research on drug safety assestment
Action research on drug safety assestmentReymart Bargamento
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...ErikaAGoyer
 

Similar to Medication Abuse Handouts by Rand L. Kannenberg (20)

EVERFI Webinar: Evidence Based Prescription Drugs Program
EVERFI Webinar: Evidence Based Prescription Drugs ProgramEVERFI Webinar: Evidence Based Prescription Drugs Program
EVERFI Webinar: Evidence Based Prescription Drugs Program
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willis
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah ChouinardFMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
 
Sub m mw actual
Sub m mw actualSub m mw actual
Sub m mw actual
 
Cannabis talk 6 4-19 glenview
Cannabis talk 6 4-19 glenviewCannabis talk 6 4-19 glenview
Cannabis talk 6 4-19 glenview
 
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
National epidemiologic survey on alcohol and related conditions.seminar coorect
National epidemiologic survey on alcohol and related conditions.seminar coorectNational epidemiologic survey on alcohol and related conditions.seminar coorect
National epidemiologic survey on alcohol and related conditions.seminar coorect
 
Prescription Opioids and African Americans Research Paper
Prescription Opioids and African Americans Research PaperPrescription Opioids and African Americans Research Paper
Prescription Opioids and African Americans Research Paper
 
CDC Opioid Prescribing Guidelines
CDC Opioid Prescribing GuidelinesCDC Opioid Prescribing Guidelines
CDC Opioid Prescribing Guidelines
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
 
8b3110 5e86f9f991724f258390ca750d1c321a
8b3110 5e86f9f991724f258390ca750d1c321a8b3110 5e86f9f991724f258390ca750d1c321a
8b3110 5e86f9f991724f258390ca750d1c321a
 
Final Paper
Final PaperFinal Paper
Final Paper
 
Prescribing Opioids in the ED
Prescribing Opioids in the EDPrescribing Opioids in the ED
Prescribing Opioids in the ED
 
Action research on drug safety assestment
Action research on drug safety assestmentAction research on drug safety assestment
Action research on drug safety assestment
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
 

More from Rand Kannenberg

Comments from rand kannenberg's students page 2 of 2
Comments from rand kannenberg's students page 2 of 2Comments from rand kannenberg's students page 2 of 2
Comments from rand kannenberg's students page 2 of 2Rand Kannenberg
 
Comments from rand kannenberg's students page 1 of 2
Comments from rand kannenberg's students page 1 of 2Comments from rand kannenberg's students page 1 of 2
Comments from rand kannenberg's students page 1 of 2Rand Kannenberg
 
Rand kannenberg still shots media archived (abc, cbs, nbc) and state video
Rand kannenberg still shots media archived (abc, cbs, nbc) and state videoRand kannenberg still shots media archived (abc, cbs, nbc) and state video
Rand kannenberg still shots media archived (abc, cbs, nbc) and state videoRand Kannenberg
 
APD SUD by Rand L. Kannenberg
APD SUD by Rand L. KannenbergAPD SUD by Rand L. Kannenberg
APD SUD by Rand L. KannenbergRand Kannenberg
 
Methamphetamine by Rand L. Kannenberg
Methamphetamine by Rand L. KannenbergMethamphetamine by Rand L. Kannenberg
Methamphetamine by Rand L. KannenbergRand Kannenberg
 
Clinical Sobriety Checklist by Rand L. Kannenberg
Clinical Sobriety Checklist by Rand L. KannenbergClinical Sobriety Checklist by Rand L. Kannenberg
Clinical Sobriety Checklist by Rand L. KannenbergRand Kannenberg
 
Interventions by Rand L. Kannenberg
Interventions by Rand L. KannenbergInterventions by Rand L. Kannenberg
Interventions by Rand L. KannenbergRand Kannenberg
 
Rand Kannenberg Theories And Models Of Helping Offenders Change
Rand Kannenberg   Theories And Models Of Helping Offenders ChangeRand Kannenberg   Theories And Models Of Helping Offenders Change
Rand Kannenberg Theories And Models Of Helping Offenders ChangeRand Kannenberg
 
Rand Kannenberg Professional Ethics In Corrections
Rand Kannenberg   Professional Ethics In CorrectionsRand Kannenberg   Professional Ethics In Corrections
Rand Kannenberg Professional Ethics In CorrectionsRand Kannenberg
 
Rand Kannenberg Cultural Diversity Skills In Community Corrections
Rand Kannenberg   Cultural Diversity Skills In Community CorrectionsRand Kannenberg   Cultural Diversity Skills In Community Corrections
Rand Kannenberg Cultural Diversity Skills In Community CorrectionsRand Kannenberg
 
Rand Kannenberg Communication Techniques With Offenders
Rand Kannenberg   Communication Techniques With OffendersRand Kannenberg   Communication Techniques With Offenders
Rand Kannenberg Communication Techniques With OffendersRand Kannenberg
 
Rand Kannenberg Deviance And Criminal Behavior
Rand Kannenberg    Deviance And Criminal BehaviorRand Kannenberg    Deviance And Criminal Behavior
Rand Kannenberg Deviance And Criminal BehaviorRand Kannenberg
 
Rand Kannenberg Using Humor In Offender Counseling And Supervision
Rand Kannenberg   Using Humor In Offender Counseling And SupervisionRand Kannenberg   Using Humor In Offender Counseling And Supervision
Rand Kannenberg Using Humor In Offender Counseling And SupervisionRand Kannenberg
 

More from Rand Kannenberg (13)

Comments from rand kannenberg's students page 2 of 2
Comments from rand kannenberg's students page 2 of 2Comments from rand kannenberg's students page 2 of 2
Comments from rand kannenberg's students page 2 of 2
 
Comments from rand kannenberg's students page 1 of 2
Comments from rand kannenberg's students page 1 of 2Comments from rand kannenberg's students page 1 of 2
Comments from rand kannenberg's students page 1 of 2
 
Rand kannenberg still shots media archived (abc, cbs, nbc) and state video
Rand kannenberg still shots media archived (abc, cbs, nbc) and state videoRand kannenberg still shots media archived (abc, cbs, nbc) and state video
Rand kannenberg still shots media archived (abc, cbs, nbc) and state video
 
APD SUD by Rand L. Kannenberg
APD SUD by Rand L. KannenbergAPD SUD by Rand L. Kannenberg
APD SUD by Rand L. Kannenberg
 
Methamphetamine by Rand L. Kannenberg
Methamphetamine by Rand L. KannenbergMethamphetamine by Rand L. Kannenberg
Methamphetamine by Rand L. Kannenberg
 
Clinical Sobriety Checklist by Rand L. Kannenberg
Clinical Sobriety Checklist by Rand L. KannenbergClinical Sobriety Checklist by Rand L. Kannenberg
Clinical Sobriety Checklist by Rand L. Kannenberg
 
Interventions by Rand L. Kannenberg
Interventions by Rand L. KannenbergInterventions by Rand L. Kannenberg
Interventions by Rand L. Kannenberg
 
Rand Kannenberg Theories And Models Of Helping Offenders Change
Rand Kannenberg   Theories And Models Of Helping Offenders ChangeRand Kannenberg   Theories And Models Of Helping Offenders Change
Rand Kannenberg Theories And Models Of Helping Offenders Change
 
Rand Kannenberg Professional Ethics In Corrections
Rand Kannenberg   Professional Ethics In CorrectionsRand Kannenberg   Professional Ethics In Corrections
Rand Kannenberg Professional Ethics In Corrections
 
Rand Kannenberg Cultural Diversity Skills In Community Corrections
Rand Kannenberg   Cultural Diversity Skills In Community CorrectionsRand Kannenberg   Cultural Diversity Skills In Community Corrections
Rand Kannenberg Cultural Diversity Skills In Community Corrections
 
Rand Kannenberg Communication Techniques With Offenders
Rand Kannenberg   Communication Techniques With OffendersRand Kannenberg   Communication Techniques With Offenders
Rand Kannenberg Communication Techniques With Offenders
 
Rand Kannenberg Deviance And Criminal Behavior
Rand Kannenberg    Deviance And Criminal BehaviorRand Kannenberg    Deviance And Criminal Behavior
Rand Kannenberg Deviance And Criminal Behavior
 
Rand Kannenberg Using Humor In Offender Counseling And Supervision
Rand Kannenberg   Using Humor In Offender Counseling And SupervisionRand Kannenberg   Using Humor In Offender Counseling And Supervision
Rand Kannenberg Using Humor In Offender Counseling And Supervision
 

Recently uploaded

Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDhatriParmar
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research DiscourseAnita GoswamiGiri
 
week 1 cookery 8 fourth - quarter .pptx
week 1 cookery 8  fourth  -  quarter .pptxweek 1 cookery 8  fourth  -  quarter .pptx
week 1 cookery 8 fourth - quarter .pptxJonalynLegaspi2
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptxDhatriParmar
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsPooky Knightsmith
 

Recently uploaded (20)

Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research Discourse
 
week 1 cookery 8 fourth - quarter .pptx
week 1 cookery 8  fourth  -  quarter .pptxweek 1 cookery 8  fourth  -  quarter .pptx
week 1 cookery 8 fourth - quarter .pptx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young minds
 

Medication Abuse Handouts by Rand L. Kannenberg

  • 1. MEDICATION ABUSE: Over-the-Counter & Prescription Drug Abuse & Dependence Rand L. Kannenberg, M.A., LAC, CCM, CCS
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. Schedule II. (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence. Schedule III. (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. Schedule IV. (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III. Schedule V. (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV. U.S. Drug Enforcement Administration (DEA) Schedules of controlled substances
  • 12. Opioids & morphine derivatives hydrocodone (Schedules II, III, V) Examples Hydrocodone with Acetaminophen, Vicodin®, Vicoprofen®, Tussionex®, Lortab®, Tussend®, Hycodan®, Anexsia® Nicknames vike, Watson-387 Route of Administration swallowed Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 13. Opioids & morphine derivatives oxycodone (Schedule II) Examples Roxicet®, Oxycodone with Acetaminophen, OxyContin®, Endocet®, Percocet®, Percodan®, Tylox®, Roxicodone® Nicknames Oxy, O.C., killer Route of Administration swallowed, snorted, injected Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 14.
  • 15. Opioids & morphine derivatives morphine (Schedules II, III) Examples Duramorph®, MS-Contin®, Roxanol®, Oramorph SR®, RMS® Nicknames M, Miss Emma, monkey, white stuff Route of Administration injected, swallowed, smoked Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 16. Opioids & morphine derivatives hydro-morphone (Schedule II) Examples Dilaudid ®, dihydromorphinone Nicknames Dust, Juice, Smack, D, Footballs Route of Administration swallowed, injected Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 17. Opioids & morphine derivatives opium (Schedules II, III, V) Examples laudanum, paregoric, papaver somniferum, extracts/fluid/poppy/tincture/granulated/powdered/raw, Parepectolin®, Kapectolin PG®, Kaolin®, Pectin P.G.® Nicknames big O, black stuff, block, gum, hop Route of Administration swallowed, smoked Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 18. Opioids & morphine derivatives other narcotics (Schedules II, III, IV) Examples Actiq®, Duragesic®, Sublimaze®, Fentanyl®, Demerol®, methadone, Darvon®, Darvocet®, Stadol®, Talwin®, Paregoric®, Buprenex®, propoxyphene, Propacet®, Innovar®, Mepergan®, pethidine Nicknames Apache, China girl, China white, dance fever, friend, goodfella, jackpot, murder 8, TNT, Tango and Cash Route of Administration swallowed, injected, smoked, snorted Desired Outcomes pain relief, euphoria Adverse Reactions drowsiness, nausea, constipation, confusion, sedation, respiratory arrest, unconsciousness, coma, constricted pupils, slow and shallow breathing, clammy skin, convulsions, possible death National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 19. Video #1 “Opioids” (3 minutes & 8 seconds) “ Prescription Drugs: Killing More Than Pain”
  • 20.
  • 21. CNS depressants barbiturates (Schedules II, III, IV) Examples (methohexital) Brevital®, (thiamyl) Surital®, (thiopental) Pentothal®, (amobarbital) Amyta®, (pentobarbital) Nembutal®, (secobarbital) Seconal®, (amobarbital/secobarbital) Tuinal®, (butalbital) Fiorina®, (butabarbital) Butisol®, (talbutal) Lotusate®, (aprobarbital) Alurate®, (phenobarbital) Luminal®, (mephobarbital) Mebaral® Nicknames barbs, reds, red birds, phennies, tooies, yellows, yellow jackets Route of Administration injected, swallowed Desired Outcomes reduced pain and anxiety; feeling of well-being; lowered inhibitions Adverse Reactions slowed pulse and breathing, lowered blood pressure, poor concentration/fatigue, confusion, impaired coordination/memory/judgment, respiratory depression and arrest, death, sedation, drowsiness/depression, unusual excitement, fever, irritability, poor judgment, slurred speech, dizziness, life-threatening withdrawal National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 22.
  • 23.
  • 24. Video #2 “Benzos” (2 minutes & 46 seconds) “ Prescription Drugs: Killing More Than Pain”
  • 25.
  • 26.
  • 27. Stimulants cocaine (Schedule II) Examples Cocaine hydrochloride Nicknames blow, bump, C, candy, Charlie, coke, crack, flake, rock, snow, toot Route of Administration swallowed, snorted, injected, smoked Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions dysphoric crash, death from respiratory failure, strokes, heart failure, increased heart rate, high blood pressure, increased metabolism, irregular heart beat, weight loss, nervousness, insomnia, increased temperature, chest pain, nausea, abdominal pain, seizures, headaches, malnutrition, panic attacks Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 28. Stimulants methamphetamine (Schedule II) Example Desoxyn® Nicknames chalk, crank, crystal, fire, glass, go fast, ice, meth, speed Route of Administration swallowed, snorted, injected, smoked Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions inability to sleep, loss of appetite and weight, thin/gaunt, increased sensitivity to noise, agitation, restlessness, irritability, aggressiveness, dizziness, confusion, impaired judgment, diarrhea and gastrointestinal complaints, difficulty breathing, headaches, tremors or seizures, nausea and vomiting, numbness, profuse sweating, chills, muscle cramping, pain and tenderness, dehydration, low magnesium level, low potassium level, grossly dilated pupils, chest pain, increased or decreased heart rate, increased blood pressure, fever or hyperthermia, impaired speech and language, mania, psychosis with hallucinations and delusions, anxiety, panic, fear of impending doom, depression and suicidal ideation, poor hygiene and body malodor, missing teeth, bleeding gums, infected gums, dental caries/decay/cavities, dry mouth, removed enamel, teeth grinding, skin aging and damage, dryness, roughness, wrinkles, broken veins, dermatitis around the mouth, skin ulceration and infection, acne or sores, hair loss from repetitious pulling Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 29. Stimulants methylphenidate (Schedule II) Examples Ritalin®, Methylin®, Concerta® Nicknames JIF, MPH, R-ball, Skippy, the smart drug, vitamin R Route of Administration swallowed, snorted, injected Desired Outcomes awake, alert, active, aware, appetite suppression, energy, euphoria, excitement, enthusiasm, enhancement of the senses Adverse Reactions increased heart rate, high blood pressure, increased metabolism, irregular heart beat, weight loss, heart failure, nervousness, insomnia Criminal Justice Addiction Services National Institute on Drug Abuse (NIDA) U.S. Drug Enforcement Administration (DEA)
  • 30.
  • 31.
  • 32.
  • 33. Weight loss pills Examples bitter orange, chitosan, chromium, conjugated linoleic acid (CLA), county mallow (heartleaf), ephedra, green tea extract, guar gum, hoodia Nicknames same as above Route of Administration swallowed Desired Outcomes decrease appetite, block absorption of dietary fat, reduce fat, build muscle, increase calorie and fat metabolism, increase the feeling of fullness Adverse Reactions constipation, bloating, diarrhea, indigestion, high blood pressure, heart rate irregularities, sleeplessness, seizures, heart attacks, strokes, death, vomiting, flatulence Mayo Clinic
  • 34.
  • 35.
  • 36.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64. _____legal, illegal, prescription and over-the-counter substance(s) used; _____amount/route of administration/frequency/duration of use; _____when started using; _____why using/used; _____last use; _____blood alcohol level and time; _____breath test result and time; _____urine drug screen results and time; _____CIWA score and time; _____COWS score and time; _____CAGE score; Kannenberg Prescription drug interview questions
  • 65. _____history of blackouts; _____history of intoxication or withdrawal delirium; _____history of intoxication or withdrawal seizures; _____history of substance induced psychosis, mania, anxiety or depression; _____longest time clean/sober, _____history of addiction treatment; _____history of addiction support; _____history of addiction education; _____history of substance related legal problems; _____history of physical problems as a result of using; and _____problems at home, work or school as a result of using. Kannenberg
  • 66.
  • 67.
  • 68.
  • 69. 21. Neglect food : I do not eat healthy foods or eat at regular times, especially when I'm using. 22. Resentment : I feel like other people are out to get me, and I feel angry a lot. 23. Withdrawal : I need a drink or a drug in the morning or else I get the shakes or sweats because I feel terrible. 24. Can't make decisions : I can't make decisions about even small things. I just wait until things happen. 19. Work and money troubles : I have problems on the job, owe money or can't work at all because of my using. 20. Avoid friends and family : I avoid old friends and family that do not use—unless I need something from them. 18. Make changes : I change jobs, move, or leave a relationship to try to make my life better, but it doesn't make any difference. 17. Give up other things : I've stopped doing things that I used to do that didn't involve using alcohol or drugs. 16. Control : I try to control my use, but it doesn't work. 15. Promises : I promise to get my life in order and do better. I mean it, but it doesn't work out that way. 14. Show off : I show off or get pushy with other people to feel better and prove that I am okay. 13. Feel bad : I feel bad about how my using hurts other people, but I don't know what to do about it.
  • 70. 37. Confinement : I have been in jails and mental wards because of my using. 36. Desperation : I am willing to do anything to get better. 35. I'm lost : I don't try to pretend my life is normal. I know I am an addict or an alcoholic. I believe that things will never change. 34. Turn to God : I want God or religion to save me from my life. 33. Using is everything : Getting something to use, using, and getting over using are my whole life. 32. Give up : I don't try to change anything. I just wait to see what happens. 31. Afraid : I feel like something terrible might happen to me, people are out to get me, and I have to be on guard at all times. 30. Major damage : Even when I'm not using, I have a hard time thinking, remembering, and doing things that used to be easy. 29. Find someone worse : I try to use with people who are worse off than I am so that I feel better. 28. Use all the time : I use whenever I can, and I don't try to have a normal life. 27. Over the line : I do things I said I would never do or things that do not reflect the way I was raised. 26. Decrease in amount to get high : It takes less for me to get high or doesn't matter how much I use because I can't get the effect I want. 25. Health problems : I am sick, have lost a lot of weight, or feel physically bad most of the time.
  • 71. Scoring Sheet for Alcohol and Drug Addiction Test Early Stage Addiction Count up the number of yes answers you checked in questions 1–12 and write the number below. Number of checks for questions 1–12 _____ If you have one or more checks in this section, there is a possibility that you are addicted to alcohol or drugs. This means that you use alcohol or drugs to try to solve problems and to make yourself feel better. While using alcohol or drugs will not really make things better, it will feel like it does. If you have any checks in this section, you have a possibility of becoming addicted if you keep using. The closer your score is to 12, the higher your chance of addiction. Middle Stage Addiction Count up the number of yes answers you checked in questions 13–24 and write the number below. Number of checks for questions 13–24 ____ Any number of checks in this section means that you are addicted and have started to have bad things happen to you because of your addiction. During this stage, you may try to do things to control your addiction. Some of these may work for a while, but not for long. For questions 13–24, the closer your score is to 12, the more addicted you are, and the worse things will get if you do not get help. Late Stage Addiction Count up the number of yes answers you checked in questions 25–37 and write the number below. Number of checks for questions 25–37 ____ Any number of checks in this section means that you are in the late stage of addiction. During this stage, you may have given up and thought that you could not do anything to change. Serious life problems, such as being sick, or going to jail or a mental ward, have happened or will happen to you if you do not try to get help. For questions 25–37, the closer your score is to 13, the more addicted you are. Your chances of dying are high if you continue to use.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.   For each item, write in the number that best describes the patient’s signs or symptom.  Rate on just the apparent relationship to opiate withdrawal.  For example, if heart rate is increased because the patient was jogging just prior to assessment, the increase pulse rate would not add to the score.   WESSON, Donald R., CNS Medications Development, Oakland, California; Medications Development Committee, American Society of Addiction Medicine. LING, Walter, Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at University of California, Los Angeles. Clinical Opiate Withdrawal Scale (COWS)   Patient’s Name:___________________________                         Date: ______________
  • 79.
  • 81.
  • 83.
  • 86.
  • 88.
  • 90.
  • 92.       Score: 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than 36 = severe withdrawal                                   Total scores   with observer’s initials
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.  
  • 106.  
  • 107. “ National Medicine Abuse Awareness Month ” set by the United States Senate for every August starting in 2007.
  • 108.
  • 109.
  • 110.
  • 111.